NATCO Pharma reported a 37.75% decline in Q3 FY2025 net profit, dropping to ₹132.4 crore due to a downturn in formulation ...
In a stark reflection of the challenges facing the biotech sector, Rallybio Corporation (RLYB) shares tumbled to a 52-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback